A novel missense mutation of RYR1 in familial idiopathic hyper CK-emia

Ken Sano, Shiroh Miura, Toshiya Fujiwara, Ryuta Fujioka, Akiko Yorita, Kazuhito Noda, Hiroshi Kida, Koichi Azuma, Shinjiro Kaieda, Ken Yamamoto, Takayuki Taniwaki, Yasuyuki Fukumaki, Hiroki Shibata

研究成果: ジャーナルへの寄稿記事

3 引用 (Scopus)

抄録

Abstract Persistent elevation of serum creatine kinase (CK) without any symptoms has been called idiopathic hyper CK-emia (IHCK). We examined a four-generation Japanese pedigree of familial IHCK. The multipoint linkage analysis of the pedigree showed seven clear peaks of logarithm of odds (LOD) scores (>1.4). By the exome sequencing followed by multiple filtering processes, we identified one novel heterozygous nonsynonymous single nucleotide variant (SNV), c.7034G>C, p.S2345T in the ryanodine receptor 1 gene, RYR1 cosegregated with IHCK in the pedigree. Mutation Taster predicted this substitution as "disease causing" (p = 0.999). The PolyPhen-2 and PANTHER subPSEC scores for the substitution are 0.911 (possibly damaging) and - 3.56 (probably damaging), respectively. We confirmed the absence of the SNV in 511 healthy Japanese individuals excluding the possibility of a normal variant with a very low frequency. Immunohistochemistry and Western blotting of biopsy samples consistently showed the expression level of RYR1 reduced in the patient. In real-time RT-PCR, the mRNA expression level of RYR1 was also significantly reduced in the patient (p = 0.009). These results suggest that the novel nonsynonymous SNV contribute to the vulnerability of the RYR1 protein through the dominant negative effect. We conclude that the SNV in the RYR1 gene is one of the responsible genes of IHCK.

元の言語英語
記事番号13864
ページ(範囲)142-147
ページ数6
ジャーナルJournal of the Neurological Sciences
356
発行部数1-2
DOI
出版物ステータス出版済み - 9 15 2015

Fingerprint

Missense Mutation
Creatine Kinase
Pedigree
Nucleotides
Genes
Exome
Ryanodine Receptor Calcium Release Channel
Real-Time Polymerase Chain Reaction
Western Blotting
Immunohistochemistry
Biopsy
Messenger RNA
Mutation
Serum
Proteins

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

これを引用

A novel missense mutation of RYR1 in familial idiopathic hyper CK-emia. / Sano, Ken; Miura, Shiroh; Fujiwara, Toshiya; Fujioka, Ryuta; Yorita, Akiko; Noda, Kazuhito; Kida, Hiroshi; Azuma, Koichi; Kaieda, Shinjiro; Yamamoto, Ken; Taniwaki, Takayuki; Fukumaki, Yasuyuki; Shibata, Hiroki.

:: Journal of the Neurological Sciences, 巻 356, 番号 1-2, 13864, 15.09.2015, p. 142-147.

研究成果: ジャーナルへの寄稿記事

Sano, K, Miura, S, Fujiwara, T, Fujioka, R, Yorita, A, Noda, K, Kida, H, Azuma, K, Kaieda, S, Yamamoto, K, Taniwaki, T, Fukumaki, Y & Shibata, H 2015, 'A novel missense mutation of RYR1 in familial idiopathic hyper CK-emia', Journal of the Neurological Sciences, 巻. 356, 番号 1-2, 13864, pp. 142-147. https://doi.org/10.1016/j.jns.2015.06.035
Sano K, Miura S, Fujiwara T, Fujioka R, Yorita A, Noda K その他. A novel missense mutation of RYR1 in familial idiopathic hyper CK-emia. Journal of the Neurological Sciences. 2015 9 15;356(1-2):142-147. 13864. https://doi.org/10.1016/j.jns.2015.06.035
Sano, Ken ; Miura, Shiroh ; Fujiwara, Toshiya ; Fujioka, Ryuta ; Yorita, Akiko ; Noda, Kazuhito ; Kida, Hiroshi ; Azuma, Koichi ; Kaieda, Shinjiro ; Yamamoto, Ken ; Taniwaki, Takayuki ; Fukumaki, Yasuyuki ; Shibata, Hiroki. / A novel missense mutation of RYR1 in familial idiopathic hyper CK-emia. :: Journal of the Neurological Sciences. 2015 ; 巻 356, 番号 1-2. pp. 142-147.
@article{dd6cf6dca7324572b2afd11189970ddb,
title = "A novel missense mutation of RYR1 in familial idiopathic hyper CK-emia",
abstract = "Abstract Persistent elevation of serum creatine kinase (CK) without any symptoms has been called idiopathic hyper CK-emia (IHCK). We examined a four-generation Japanese pedigree of familial IHCK. The multipoint linkage analysis of the pedigree showed seven clear peaks of logarithm of odds (LOD) scores (>1.4). By the exome sequencing followed by multiple filtering processes, we identified one novel heterozygous nonsynonymous single nucleotide variant (SNV), c.7034G>C, p.S2345T in the ryanodine receptor 1 gene, RYR1 cosegregated with IHCK in the pedigree. Mutation Taster predicted this substitution as {"}disease causing{"} (p = 0.999). The PolyPhen-2 and PANTHER subPSEC scores for the substitution are 0.911 (possibly damaging) and - 3.56 (probably damaging), respectively. We confirmed the absence of the SNV in 511 healthy Japanese individuals excluding the possibility of a normal variant with a very low frequency. Immunohistochemistry and Western blotting of biopsy samples consistently showed the expression level of RYR1 reduced in the patient. In real-time RT-PCR, the mRNA expression level of RYR1 was also significantly reduced in the patient (p = 0.009). These results suggest that the novel nonsynonymous SNV contribute to the vulnerability of the RYR1 protein through the dominant negative effect. We conclude that the SNV in the RYR1 gene is one of the responsible genes of IHCK.",
author = "Ken Sano and Shiroh Miura and Toshiya Fujiwara and Ryuta Fujioka and Akiko Yorita and Kazuhito Noda and Hiroshi Kida and Koichi Azuma and Shinjiro Kaieda and Ken Yamamoto and Takayuki Taniwaki and Yasuyuki Fukumaki and Hiroki Shibata",
year = "2015",
month = "9",
day = "15",
doi = "10.1016/j.jns.2015.06.035",
language = "English",
volume = "356",
pages = "142--147",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A novel missense mutation of RYR1 in familial idiopathic hyper CK-emia

AU - Sano, Ken

AU - Miura, Shiroh

AU - Fujiwara, Toshiya

AU - Fujioka, Ryuta

AU - Yorita, Akiko

AU - Noda, Kazuhito

AU - Kida, Hiroshi

AU - Azuma, Koichi

AU - Kaieda, Shinjiro

AU - Yamamoto, Ken

AU - Taniwaki, Takayuki

AU - Fukumaki, Yasuyuki

AU - Shibata, Hiroki

PY - 2015/9/15

Y1 - 2015/9/15

N2 - Abstract Persistent elevation of serum creatine kinase (CK) without any symptoms has been called idiopathic hyper CK-emia (IHCK). We examined a four-generation Japanese pedigree of familial IHCK. The multipoint linkage analysis of the pedigree showed seven clear peaks of logarithm of odds (LOD) scores (>1.4). By the exome sequencing followed by multiple filtering processes, we identified one novel heterozygous nonsynonymous single nucleotide variant (SNV), c.7034G>C, p.S2345T in the ryanodine receptor 1 gene, RYR1 cosegregated with IHCK in the pedigree. Mutation Taster predicted this substitution as "disease causing" (p = 0.999). The PolyPhen-2 and PANTHER subPSEC scores for the substitution are 0.911 (possibly damaging) and - 3.56 (probably damaging), respectively. We confirmed the absence of the SNV in 511 healthy Japanese individuals excluding the possibility of a normal variant with a very low frequency. Immunohistochemistry and Western blotting of biopsy samples consistently showed the expression level of RYR1 reduced in the patient. In real-time RT-PCR, the mRNA expression level of RYR1 was also significantly reduced in the patient (p = 0.009). These results suggest that the novel nonsynonymous SNV contribute to the vulnerability of the RYR1 protein through the dominant negative effect. We conclude that the SNV in the RYR1 gene is one of the responsible genes of IHCK.

AB - Abstract Persistent elevation of serum creatine kinase (CK) without any symptoms has been called idiopathic hyper CK-emia (IHCK). We examined a four-generation Japanese pedigree of familial IHCK. The multipoint linkage analysis of the pedigree showed seven clear peaks of logarithm of odds (LOD) scores (>1.4). By the exome sequencing followed by multiple filtering processes, we identified one novel heterozygous nonsynonymous single nucleotide variant (SNV), c.7034G>C, p.S2345T in the ryanodine receptor 1 gene, RYR1 cosegregated with IHCK in the pedigree. Mutation Taster predicted this substitution as "disease causing" (p = 0.999). The PolyPhen-2 and PANTHER subPSEC scores for the substitution are 0.911 (possibly damaging) and - 3.56 (probably damaging), respectively. We confirmed the absence of the SNV in 511 healthy Japanese individuals excluding the possibility of a normal variant with a very low frequency. Immunohistochemistry and Western blotting of biopsy samples consistently showed the expression level of RYR1 reduced in the patient. In real-time RT-PCR, the mRNA expression level of RYR1 was also significantly reduced in the patient (p = 0.009). These results suggest that the novel nonsynonymous SNV contribute to the vulnerability of the RYR1 protein through the dominant negative effect. We conclude that the SNV in the RYR1 gene is one of the responsible genes of IHCK.

UR - http://www.scopus.com/inward/record.url?scp=84939252499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939252499&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2015.06.035

DO - 10.1016/j.jns.2015.06.035

M3 - Article

C2 - 26119398

AN - SCOPUS:84939252499

VL - 356

SP - 142

EP - 147

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

M1 - 13864

ER -